Liminal Biosciences Inc (LMNL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Sales | 308 | 513 | 2,476 | 3,696 | 36,549 |
| Cost of Goods | N/A | N/A | 1,518 | 2,082 | 29,319 |
| Gross Profit | 308 | 513 | 959 | 1,614 | 7,231 |
| Operating Expenses | 25,510 | 40,114 | 71,717 | 90,813 | 95,366 |
| Operating Income | -25,201 | -39,601 | -70,241 | -89,118 | -87,817 |
| Interest Expense | 829 | 5,051 | 6,705 | 10,593 | 17,019 |
| Other Income | 3,385 | 8,791 | -14,379 | -76,980 | -94,145 |
| Pre-tax Income | -22,646 | -35,862 | -91,325 | -176,690 | -198,981 |
| Income Tax | -404 | 94 | -150 | -179 | -15,445 |
| Net Income Continuous | -22,242 | -35,956 | -88,652 | -156,657 | -183,537 |
| Net Income Discontinuous | 22,721 | 45,701 | N/A | 848 | N/A |
| Minority Interests | 94 | -534 | -621 | -787 | -32,812 |
| Net Income | $385 | $10,279 | $-88,031 | $-155,022 | $-150,725 |
| EPS Basic Total Ops | 0.12 | 3.43 | -36.06 | -96.54 | -2,080.00 |
| EPS Basic Continuous Ops | -7.17 | -11.92 | -36.28 | -97.53 | -2,562.62 |
| EPS Basic Discontinuous Ops | 7.32 | 15.15 | N/A | 0.53 | N/A |
| EPS Diluted Total Ops | 0.12 | 3.43 | -36.06 | -96.54 | -2,080.00 |
| EPS Diluted Continuous Ops | -7.17 | -11.92 | -36.28 | -97.53 | -2,562.62 |
| EPS Diluted Discontinuous Ops | 7.32 | 15.15 | N/A | 0.53 | N/A |
| EPS Diluted Before Non-Recurring Items | -7.20 | -11.70 | -30.60 | -109.40 | -800.00 |
| EBITDA(a) | $-24,340 | $-36,135 | $-63,936 | $-81,653 | $-83,606 |